Heart:婴幼儿采用微创封堵与开放手术进行室间隔缺损封堵的比较

2018-07-05 xiangting MedSci原创

对于pmVSD婴幼儿,与手术封堵相比,微创封堵可降低术后心肺功能受损的发生率。

目前缺乏关于微创封堵临床疗效、安全性和心肺表现的有力证据。这项研究分析了膜周室间隔缺损(pmVSDs)微创封堵的围手术期疗效、安全性和心肺表现。

年龄5-60个月初次手术的单纯性pmVSD婴幼儿被随机分组接受标准开放手术或微创封堵术。微创封堵术为导管经剑突下切口直接进入心室。主要结局包括出院时的完全闭合,主要和轻微不良事件以及围手术期心肺功能从基线开始的变化。完全闭合主要在改良的意向治疗(mITT)人群中进行分析,对ITT、每个方案(PP)和治疗后(AT)人群(非劣效性界值-5.0%)进行敏感性分析。

这项研究招募了200名pmVSDs患者(平均年龄24.38个月,范围7-58个月,104名女孩),其中100名患者被随机分配到一个研究组。在ITT(绝对差异-0.010(95%CI -0.078-0.058))和mITT人群中(-0.010(95%CI -0.069-0.048))微创封堵与手术封堵出院时的完全闭合未表现出非劣效性,但在PP(0.010(95%CI -0.043-0.062))和AT人群中(0.048(95%CI -0.009-0.106))中出现非劣效性。与手术封堵相比,微创封堵降低了心脏血流动力学、电生理反应、心肌细胞活力、呼吸力学、通气和气体交换功能以及氧合和组织灌注的损害率(所有组间P均<0.05)。

对于pmVSD婴幼儿,与手术封堵相比,微创封堵可降低术后心肺功能受损的发生率,但完全闭合的非劣效性应在特定人群的背景下进行解释。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1924280, encodeId=29f6192428074, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Thu Jan 03 15:00:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037868, encodeId=3c58203e86830, content=<a href='/topic/show?id=990249651d8' target=_blank style='color:#2F92EE;'>#开放手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49651, encryptionId=990249651d8, topicName=开放手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Mon Aug 20 04:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317029, encodeId=dd3f131e029d3, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356839, encodeId=5f0d1356839cb, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562931, encodeId=58ab156293199, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1924280, encodeId=29f6192428074, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Thu Jan 03 15:00:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037868, encodeId=3c58203e86830, content=<a href='/topic/show?id=990249651d8' target=_blank style='color:#2F92EE;'>#开放手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49651, encryptionId=990249651d8, topicName=开放手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Mon Aug 20 04:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317029, encodeId=dd3f131e029d3, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356839, encodeId=5f0d1356839cb, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562931, encodeId=58ab156293199, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1924280, encodeId=29f6192428074, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Thu Jan 03 15:00:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037868, encodeId=3c58203e86830, content=<a href='/topic/show?id=990249651d8' target=_blank style='color:#2F92EE;'>#开放手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49651, encryptionId=990249651d8, topicName=开放手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Mon Aug 20 04:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317029, encodeId=dd3f131e029d3, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356839, encodeId=5f0d1356839cb, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562931, encodeId=58ab156293199, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=)]
    2018-07-07 vera_1203
  4. [GetPortalCommentsPageByObjectIdResponse(id=1924280, encodeId=29f6192428074, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Thu Jan 03 15:00:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037868, encodeId=3c58203e86830, content=<a href='/topic/show?id=990249651d8' target=_blank style='color:#2F92EE;'>#开放手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49651, encryptionId=990249651d8, topicName=开放手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Mon Aug 20 04:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317029, encodeId=dd3f131e029d3, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356839, encodeId=5f0d1356839cb, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562931, encodeId=58ab156293199, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=)]
    2018-07-07 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=1924280, encodeId=29f6192428074, content=<a href='/topic/show?id=a1444624457' target=_blank style='color:#2F92EE;'>#室间隔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46244, encryptionId=a1444624457, topicName=室间隔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05202500204, createdName=minhuang75_72521584, createdTime=Thu Jan 03 15:00:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037868, encodeId=3c58203e86830, content=<a href='/topic/show?id=990249651d8' target=_blank style='color:#2F92EE;'>#开放手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49651, encryptionId=990249651d8, topicName=开放手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Mon Aug 20 04:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317029, encodeId=dd3f131e029d3, content=<a href='/topic/show?id=df8950505a2' target=_blank style='color:#2F92EE;'>#微创#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50505, encryptionId=df8950505a2, topicName=微创)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356839, encodeId=5f0d1356839cb, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562931, encodeId=58ab156293199, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 07 01:00:00 CST 2018, time=2018-07-07, status=1, ipAttribution=)]
    2018-07-07 slcumt

相关资讯

JACC:梗死后室间隔缺损的体内形态学及闭合的影响

这是首个在活体患者中关于PIVSD的详细解剖描述。收缩期或舒张期缺损可能会更大,这意味着单相测量是不合适的。

Circulation:儿童进行圆锥动脉干畸形修复术后要警惕室间隔缺损!

壁内室间隔缺损(VSDs)通过右心室游离壁进行室内通信,可发生在修复圆锥动脉干畸形后。研究人员评估了残余的VSDs患病率及其对术后效果的影响。该研究的参与者是从2006年1月1日至2013年6月30日之间接受圆锥动脉干畸形双心室修复的孩子们,并且对其术后经胸超声心动图检查进行了分析。研究人员利用图像对室内和非室内VSDs进行了复查。主要终点是复合的死亡率,体外膜肺氧合(ECMO)的使用,以及对后续